Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing

The Journal of Infectious Diseases
Sascha A KristianRegine Landmann

Abstract

Biofilm formation is considered to be an important virulence factor of the opportunistic pathogen Staphylococcus epidermidis. We hypothesized that biofilm formation could interfere with the deposition of immunoglobulins and complement on the bacterial surface, leading to diminished activation of the complement system and protection from killing by human phagocytes. The killing of biofilm-encased and planktonically grown wild-type (wt) S. epidermidis and the killing of an isogenic biofilm-negative ica mutant (ica(-)) by human polymorphonuclear neutrophils (PMNs) were compared. C3a induction and deposition of C3b and immunoglobulin G (IgG) on the bacteria after opsonization with human serum were assessed by enzyme-linked immunosorbent assay, flow cytometry, and electron microscopy. The virulence of the bacterial strains was compared in a mouse model of catheter-associated infection. Biofilm-embedded wt S. epidermidis was killed less well by human PMNs and induced more C3a than planktonically grown wt and ica(-) S. epidermidis. However, the deposition of C3b and IgG on the bacterial surface was diminished in biofilm-encased staphylococci. wt S. epidermidis was more virulent in implant-associated infections and was killed more slow...Continue Reading

References

Oct 1, 1986·Infection and Immunity·G M JohnsonP G Quie
Nov 1, 1988·Journal of Medical Microbiology·K G KristinssonR C Spencer
Aug 1, 1986·Journal of Medical Microbiology·L A Clark, C S Easmon
Apr 1, 1984·The Journal of Clinical Investigation·W ZimmerliF A Waldvogel
Nov 1, 1994·Journal of Structural Biology·N Panté, U Aebi
Aug 1, 1994·FEMS Immunology and Medical Microbiology·J RodgersC Olliff
May 21, 1999·Science·J W CostertonE P Greenberg
Jun 12, 2001·Methods in Enzymology·S E CramtonF Götz
Jul 11, 2001·Journal of Medical Microbiology·J P O'Gara, H Humphreys
Apr 5, 2002·Microbes and Infection·Cuong Vuong, Michael Otto
Apr 16, 2002·Molecular Microbiology·Friedrich Götz
Nov 1, 2002·The Lancet Infectious Diseases·Christof von EiffChristine Heilmann
Mar 6, 2004·Science·Volker BrinkmannArturo Zychlinsky
May 18, 2006·The International Journal of Artificial Organs·D MackJ K-M Knobloch

❮ Previous
Next ❯

Citations

May 27, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Adrianna PodbielskaWaldemar L Olszewski
May 24, 2011·Seminars in Immunopathology·Werner Zimmerli, Parham Sendi
Nov 19, 2011·Seminars in Immunopathology·Michael Otto
Jul 18, 2009·Nature Reviews. Microbiology·Michael Otto
Mar 15, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Fernanda GomesRosário Oliveira
Oct 4, 2012·The Journal of Infectious Diseases·Zhihong XieAnna Dongari-Bagtzoglou
Nov 18, 2008·The Journal of Antimicrobial Chemotherapy·Kristina FlemmingTrond Flaegstad
Feb 25, 2010·Current Opinion in Infectious Diseases·Gordon Y C Cheung, Michael Otto
Jan 9, 2013·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Krishnan VengadesanSthanam V L Narayana
May 18, 2011·Antimicrobial Agents and Chemotherapy·Anne-K JohnRegine Landmann
Jul 22, 2009·Antimicrobial Agents and Chemotherapy·Richard KuehlRegine Landmann
May 8, 2013·Infection and Immunity·Mirian DomenechJose Yuste
Feb 2, 2011·Infection and Immunity·Ranjani PrabhakaraMark E Shirtliff
Jun 5, 2010·Future Microbiology·Paul D Fey, Michael E Olson
Oct 31, 2015·Future Microbiology·Sharon KleinschmidtLouise M Hafner
Feb 26, 2010·Molecular Microbiology·Martin LappannUlrich Vogel
Oct 4, 2011·Microbiology·Marat R SadykovGreg A Somerville
Aug 27, 2014·Journal of Neuroimmunology·Yenis Gutierrez-Murgas, Jessica N Snowden
Dec 11, 2013·Beneficial Microbes·G J M Christensen, H Brüggemann
Nov 21, 2013·Pulmonary Pharmacology & Therapeutics·M CataldiO Piazza
Mar 6, 2015·Frontiers in Cellular and Infection Microbiology·Henning BüttnerHolger Rohde
Nov 15, 2011·FEMS Immunology and Medical Microbiology·Elizabeth G Aarag FredheimClaus Klingenberg
Oct 4, 2014·Clinical Microbiology Reviews·Karsten BeckerGeorg Peters
Aug 26, 2014·BMC Infectious Diseases·Shruti BansalSanjay Chhibber
Jul 20, 2016·Vox Sanguinis·M TahaS Ramirez-Arcos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.